Quick Answer
Yubo International Biotech Ltd reported Stockholders Equity of -$1.95 million for the year ending 2025.
- Yubo International Biotech Ltd showed an increase of +42.9% in Stockholders Equity from 2024 to 2025.
- This data is from Yubo International Biotech Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: -$1.26 million | Q2 2016: -$1.29 million | Q3 2016: -$1.33 million | Q4 2016: -$1.37 million | Q2 2017: -$1.42 million | Q3 2017: -$1.46 million | Q4 2017: -$1.50 million | Q2 2018: -$1.56 million | Q3 2018: -$1.60 million | Q4 2018: -$1.63 million | Q1 2019: -$1.66 million | Q2 2019: -$1.70 million | Q3 2019: -$1.73 million | Q4 2019: -$1.77 million | Q1 2020: -$1.80 million | Q1 2020: $828.2 thousand | Q2 2020: -$1.83 million | Q2 2020: $786.2 thousand | Q3 2020: -$1.48 million | Q3 2020: $520.0 thousand | Q4 2020: -$9.7 thousand | Q1 2021: $926.5 thousand | Q2 2021: $569.6 thousand | Q3 2021: $222.3 thousand | Q1 2022: -$760.1 thousand | Q2 2022: -$1.25 million | Q3 2022: -$658.1 thousand | Q1 2023: -$838.8 thousand | Q2 2023: -$1.15 million | Q3 2023: -$1.10 million | Q1 2024: -$2.07 million | Q2 2024: -$2.52 million | Q3 2024: -$3.13 million | Q1 2025: -$3.67 million | Q2 2025: -$4.00 million | Q3 2025: -$1.66 million.
- Over the full 17 years of available data (2011 to 2025), Yubo International Biotech Ltd's Stockholders Equity has declined by 171.9%.
- Historical annual values: Fiscal year 2025: -$1.95 million | Fiscal year 2024: -$3.42 million | Fiscal year 2023: -$1.84 million | Fiscal year 2022: -$565.4 thousand | Fiscal year 2021: -$131.2 thousand | Fiscal year 2020: $1.17 million | Fiscal year 2020: -$1.80 million | Fiscal year 2019: $488.7 thousand | Fiscal year 2019: -$1.66 million | Fiscal year 2018: -$1.52 million | Fiscal year 2017: -$1.37 million | Fiscal year 2016: -$1.26 million | Fiscal year 2015: -$1.13 million | Fiscal year 2014: -$1.01 million | Fiscal year 2013: -$906.0 thousand | Fiscal year 2012: -$803.0 thousand | Fiscal year 2011: -$719.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: